| Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research CM Moloney, VJ Lowe, ME Murray Alzheimer's & dementia 17 (9), 1554-1574, 2021 | 187 | 2021 |
| Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease AM Crist, KM Hinkle, X Wang, CM Moloney, BJ Matchett, SA Labuzan, ... Nature communications 12 (1), 2311, 2021 | 58 | 2021 |
| Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3 C Moloney, S Rayaprolu, J Howard, S Fromholt, H Brown, M Collins, ... Acta neuropathologica communications 6, 1-13, 2018 | 27 | 2018 |
| Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain CM Moloney, SA Labuzan, JE Crook, H Siddiqui, M Castanedes‐Casey, ... Alzheimer's & Dementia 19 (3), 1029-1040, 2023 | 24 | 2023 |
| Heterogeneity of Matrin 3 in the developing and aging murine central nervous system S Rayaprolu, S D'Alton, K Crosby, C Moloney, J Howard, C Duffy, ... Journal of Comparative Neurology 524 (14), 2740-2752, 2016 | 23 | 2016 |
| Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels ME Murray, CM Moloney, N Kouri, JA Syrjanen, BJ Matchett, ... Molecular neurodegeneration 17 (1), 85, 2022 | 21 | 2022 |
| RETRACTED ARTICLE: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype C Moloney, S Rayaprolu, J Howard, S Fromholt, H Brown, M Collins, ... Acta neuropathologica communications 4, 1-12, 2016 | 18 | 2016 |
| Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis S Rayaprolu, YB Seven, J Howard, C Duffy, M Altshuler, C Moloney, ... Molecular and Cellular Neuroscience 92, 17-26, 2018 | 17 | 2018 |
| Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease. Nat Commun 12: 1–17 AM Crist, KM Hinkle, X Wang, CM Moloney, BJ Matchett, SA Labuzan, ... | 13 | 2021 |
| Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease J Graff-Radford, MM Mielke, EI Hofrenning, N Kouri, TG Lesnick, ... Neurobiology of aging 119, 1-7, 2022 | 5 | 2022 |
| Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5 AM Crist, KM Hinkle, X Wang, CM Moloney, BJ Matchett, SA Labuzan, ... bioRxiv, 2020.12. 18.423469, 2020 | 4 | 2020 |
| Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease N Kouri, I Frankenhauser, Z Peng, SA Labuzan, BDC Boon, CM Moloney, ... JAMA neurology 81 (6), 619-629, 2024 | 2 | 2024 |
| Phosphorylated tau fluid biomarker sites recognize earlier neurofibrillary tangle maturity levels in the postmortem Alzheimer’s disease brain CM Moloney, SA Labuzan, JE Crook, H Siddiqui, M Castanedes-Casey, ... bioRxiv, 2021.08. 25.457363, 2021 | 2 | 2021 |
| Plasma biomarkers of amyloid and neurodegeneration predictive of neuropathologic scales of cerebrovascular disease J Graff‐Radford, MM Mielke, EI Hofrenning, N Kouri, T Lesnick, ... Alzheimer's & Dementia 18, e067350, 2022 | 1 | 2022 |
| Neurofibrillary tangle characterization in the olfactory bulb among clinicopathologic subtypes of Alzheimer’s disease JL Chalk, R Kwan, NB Martin, CM Moloney, BDC Boon, SR Dunlop, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Plasma and MRI biomarkers predict post-mortem tau pathology M Hu, CM Moloney, SA Przybelski, A Algeciras-Schimnich, AJ Fought, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Older predicted age using AI EKG-based age prediction is associated with higher Alzheimer’s disease neuropathologic change C Bermudez, JA Syrjanen, ZI Attia, PA Friedman, F Lopez-Jimenez, M Hu, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Effect of cerebrovascular risk factors on the prediction of Alzheimer’s disease neuropathologic change using plasma biomarkers (N4. 003) C Bermudez, J Syrjanen, R Petersen, D Knopman, V Ramanan, C Jack, ... Neurology 102 (17_supplement_1), 2811, 2024 | | 2024 |
| Tangle and neuritic burden from neurofibrillary tangle maturity markers in the hippocampus are differentially correlated to tau‐PET, MRI, and cognitive measures CM Moloney, Z Peng, AC Wood, DM Rothberg, MH Rutledge, ... Alzheimer's & Dementia 19, e077920, 2023 | | 2023 |
| The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study BJ Matchett, SJ Lincoln, M Baker, N Tamvaka, SA Labuzan, TNH Sirmans, ... Medicine 102 (24), e34017, 2023 | | 2023 |
